0

Tesaglitazar

Niklaus Kamber, Timothy M E Davis

IDrugs. 2005 Nov;8(11):927-35.

PMID: 16254788

Abstract:

AstraZeneca plc is developing tesaglitazar, an oral dual peroxisome proliferator-activated receptor alpha/gamma agonist, for the potential improvement of dyslipidemia and glycemic control in type 2 diabetic patients.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP251565852 Tesaglitazar Tesaglitazar 251565-85-2 Price
qrcode